Abstract

Cytochrome P450 products and renal function in cirrhosis: the HETE is on.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Acute kidney injury (AKI) in cirrhosis: Should we change current definition and diagnostic criteria of renal failure in cirrhosis?
Vicente Arroyo
Journal of Hepatology | VOL. 59
Vicente ArroyoVicente Arroyo
31 May 2013
Altered circadian hemodynamic and renal function in cirrhosis.
Suthat Liangpunsakul ... Rajiv Agarwal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | VOL. 32
Suthat Liangpunsakul, et. al.Suthat Liangpunsakul ... Rajiv Agarwal
29 Feb 2016
Chronic Kidney Disease–Epidemiology Formula and Model for End-Stage Liver Disease Score in the Assessment of Renal Function in Candidates for Liver Transplantation
F Tinti ... A.P Mitterhofer
Transplantation Proceedings | VOL. 42
F Tinti, et. al.F Tinti ... A.P Mitterhofer
01 May 2010
Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial.
Mads Israelsen ... Annette Dam Fialla
American Journal of Physiology-Gastrointestinal and Liver Physiology | VOL. 318
Mads Israelsen, et. al.Mads Israelsen ... Annette Dam Fialla
16 Dec 2019
View more papers

More From: Hepatology (Baltimore, Md.)

Paper Title
Journal
Date
Author
Letter to the editor: Bridging the gap between hepatitis C virus diagnosis and treatment to achieve elimination in the united states.
Chrysovalantis Stafylis ... Jeffrey D Klausner
Hepatology (Baltimore, Md.) | VOL. -
Chrysovalantis Stafylis, et. al.Chrysovalantis Stafylis ... Jeffrey D Klausner
08 Aug 2024
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary strictures.
Jesus M Banales ... Luca Fabris
Hepatology (Baltimore, Md.) | VOL. -
Jesus M Banales, et. al.Jesus M Banales ... Luca Fabris
08 Aug 2024
Back to phosphodiesterase inhibitors for liver disease: are we ready for clinical trials?
Leila Gobejishvili ... Craig J Mcclain
Hepatology (Baltimore, Md.) | VOL. -
Leila Gobejishvili, et. al.Leila Gobejishvili ... Craig J Mcclain
08 Aug 2024
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease.
Ying Shang ... Hannes Hagström
Hepatology (Baltimore, Md.) | VOL. -
Ying Shang, et. al.Ying Shang ... Hannes Hagström
07 Aug 2024
View more papers